Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil in labor: intermittent versus continuous intravenous infusion
2011-004823-11Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of remifentanil in labor pain (2 arms), sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoint: Pain intensity at 60 minutes. Started Aug 2012; status: completed.
02
Drugs
remifentanil
03
Conditions
labor pain
Beyond the preview
Go deeper on 2011-004823-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004823-11.